Howard county considers Elkridge to setup drug treatment center
Category: #health  By Pankaj Singh  Date: 2018-04-14
  • share
  • Twitter
  • Facebook
  • LinkedIn

Howard county considers Elkridge to setup drug treatment center

Howard county, a region that made it to the headlines due to its soaring numbers of opioid related fatalities, is expected to witness the construction of its first residential drug treatment center in Elkridge. Reportedly, the possible site is adjacent to the Mayfield Maintenance Facility.

The three bids presented by architectural firms to survey the Mayfield site are being reviewed by Howard county officials to determine if the land is sufficient to house the facility. Whether the three-acre Mayfield site is the right choice will be known after the completion of the survey which is estimated to cost around $100,000. The county has set aside a budget of $250,000 for the project planning and survey.

Speaking on the development, Director of Policy and Programs, Carl DeLorenzo reportedly said that the maintenance facility will be moved to make space for the treatment center. He further stated that once the Mayfield site is chosen to be right, the next major step will be to decide whether the facility should be county owned or privately owned.

As per reliable sources, the decision would be based on the cost comparison of a public vs private owned facility and how quickly it can be built as Howard county urgently needs a drug treatment center.

According to the county police, from the beginning of 2018 till April 9th there had been 77 cases of fatal and non-fatal opioid overdose. The number has climbed when compared to the overdose cases for the same time span in 2017.

The project has been included in the proposed 2019 capital budget by County Executive Allan Kittleman though funds are yet to be allocated to the facility. It is expected to open in 2023 and the project description includes an estimated budget of $14.8 million. However, according to reliable sources, the dates and the budget are dependent on the pace at which the project moves forward.



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Anova Enterprises expands AnovaOS™ to boost clinical development
Anova Enterprises expands AnovaOS™ to boost clinical development
By Pankaj Singh

The U.S-based Anova Enterprises, Inc. (Anova) has reportedly expanded the AnovaOS™ technology platform in order to boost the development of promising novel treatments. The platform brings pharmaceutical companies...

Serum Institute to Resume Oxford COVID-19 Vaccine’s Trail in India
Serum Institute to Resume Oxford COVID-19 Vaccine’s Trail in India
By Pankaj Singh

India’s Drugs Controller General (DCGI) has approved Pune-based Serum Institute of India (SII) to restart the clinical trial of the Oxford/AstraZeneca COVID-19 vaccine in India.

Everest Medicines Announces Cefepime-Taniborbactam Phase 1 Results

Everest Medicines Announces Cefepime-Taniborbactam Phase 1 Results
By Pankaj Singh

Everest Medicines announced the top-line results from the Phase 1 clinical trial of Taniborbactam with cefepime for treating infections caused by multi-drug resistant pathogens in China. Everest Medicines is a biopharm...